Gracell Biotechnologies (GRCL) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free GRCL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGRCL Mar 2024 10.000 call(CONTRfinance.yahoo.com - March 3 at 12:04 AM49,158 Shares in Gracell Biotechnologies Inc. (NASDAQ:GRCL) Purchased by Pathstone Family Office LLCmarketbeat.com - February 24 at 4:27 AMGracell Biotechnologies Acquisition Completedfinance.yahoo.com - February 22 at 10:23 AMGracell Biotechnologies (NASDAQ:GRCL) Given Hold Rating at Stifel Nicolausmarketbeat.com - February 22 at 9:38 AMGracell Biotechnologies Acquisition Completedglobenewswire.com - February 22 at 8:45 AMmarketbeat.com - February 22 at 6:11 AMBarclays PLC Increases Stake in Gracell Biotechnologies Inc. (NASDAQ:GRCL)marketbeat.com - February 22 at 4:14 AMAstraZeneca Deal For Gracell Biotechnologies Closing Tomorrow (Includes CVR)seekingalpha.com - February 21 at 11:51 AMGracell Biotechnologies Inc. (GRCL)investing.com - February 21 at 1:55 AMStock Traders Buy High Volume of Gracell Biotechnologies Put Options (NASDAQ:GRCL)marketbeat.com - February 20 at 11:33 AMGracell Biotechnologies Inc.: Gracell Biotechnologies Announces Shareholders' Approval of Merger Agreementfinanznachrichten.de - February 20 at 10:43 AMGracell Biotechnologies Announces Shareholders’ Approval of Merger Agreementfinance.yahoo.com - February 20 at 10:43 AMGracell Biotechnologies Announces Shareholders' Approval of Merger Agreementglobenewswire.com - February 20 at 7:45 AMGRCL Mar 2024 2.500 callfinance.yahoo.com - February 17 at 6:25 PMGRCL Gracell Biotechnologies Inc.seekingalpha.com - February 17 at 8:24 AMGracell Biotechnologies Inc. (NASDAQ:GRCL) Given Consensus Rating of "Moderate Buy" by Brokeragesmarketbeat.com - February 10 at 1:29 AMGracell Biotechnologies (NASDAQ:GRCL) Sets New 12-Month High at $10.36marketbeat.com - February 9 at 3:55 PMGracell Biotechnologies Inc. (NASDAQ:GRCL) is Vivo Capital LLC's 9th Largest Positionmarketbeat.com - February 6 at 1:39 PMGracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myelomafinance.yahoo.com - January 29 at 9:45 AMAstraZeneca: Rebound in 2024 with double-digit earnings growth (GRCL)marketbeat.com - January 11 at 6:20 AMGracell Biotechnologies Inc. Sponsored ADR (GRCL) is a Great Momentum Stock: Should You Buy?finance.yahoo.com - January 3 at 5:36 PMGRACELL BIOTECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ...businesswire.com - December 31 at 11:28 PMBarclays PLC Trims Stock Position in Gracell Biotechnologies Inc. (NASDAQ:GRCL)marketbeat.com - December 30 at 4:10 AMGracell Biotechnologies Inc. to Post FY2026 Earnings of ($0.82) Per Share, HC Wainwright Forecasts (NASDAQ:GRCL)marketbeat.com - December 29 at 7:38 AMGracell Biotechnologies (NASDAQ:GRCL) Earns "Equal Weight" Rating from Wells Fargo & Companymarketbeat.com - December 27 at 1:25 PMMaintaining Hold on Gracell Biotechnologies Amidst AstraZeneca Acquisition Prospectsmarkets.businessinsider.com - December 27 at 8:23 AMWhy China-Based Gracell Biotechnologies (GRCL) Stock Is Soaring Todaymsn.com - December 26 at 8:41 PMGracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseasesfinance.yahoo.com - December 26 at 8:41 PMGracell Biotechnologies (NASDAQ:GRCL) Stock Rating Reaffirmed by BTIG Researchmarketbeat.com - December 26 at 12:27 PMGracell Biotechnologies, Stratasys, Hollysys Automation Technologies And Other Big Stocks Moving Higher In Tuesday's Pre-Market Sessionmarkets.businessinsider.com - December 26 at 9:26 AMGRCL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Gracell Biotechnologies Inc. Is Fair to Shareholderstmcnet.com - December 26 at 9:26 AMGracell Biotechnologies Inc. (NASDAQ:GRCL) Given Average Recommendation of "Buy" by Brokeragesmarketbeat.com - December 22 at 2:20 AMGracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosusfinance.yahoo.com - December 21 at 10:13 AMGracell Biotechnologies Inc. Sponsored ADR (GRCL) Is a Great Choice for 'Trend' Investors, Here's Whyfinance.yahoo.com - December 21 at 10:13 AMPivotal bioVenture Partners Investment Advisor LLC Invests $3.96 Million in Gracell Biotechnologies Inc. (NASDAQ:GRCL)marketbeat.com - December 18 at 1:42 PMGracell Biotechnologies Inc. (NASDAQ:GRCL) Short Interest Updatemarketbeat.com - December 16 at 7:35 PMGracell Biotechnologies Presents Updated Clinical Data from FasTCAR-T GC012F Demonstrating Deep and Durable Responses in Newly Diagnosed Multiple Myeloma at ASH 2023finance.yahoo.com - December 12 at 12:02 AMWall Street Analysts Believe Gracell Biotechnologies Inc. Sponsored ADR (GRCL) Could Rally 127.82%: Here's is How to Tradefinance.yahoo.com - December 11 at 2:01 PMInstitutions own 19% of Gracell Biotechnologies Inc. (NASDAQ:GRCL) shares but private equity firms control 45% of the companyfinance.yahoo.com - December 2 at 10:23 AMBuy Rating for Gracell Biotechnologies on Promising CAR-T Cell Therapy Advancementsmarkets.businessinsider.com - November 29 at 1:20 AMEvercore ISI Group Initiates Coverage of Gracell Biotechnologies Inc - ADR (GRCL) with Outperform Recommendationmsn.com - November 28 at 3:20 PMGracell Biotechnologies Shares Rise 9%, FDA Clears Application for Lupus Treatmentmarketwatch.com - November 27 at 11:23 PMGracell Biotechnologies: FDA Clears IND Application For Phase 1/2 Trial Of FasTCAR-T GC012Fmarkets.businessinsider.com - November 27 at 1:13 PMGracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosusfinance.yahoo.com - November 27 at 1:13 PMWhat Makes Gracell Biotechnologies Inc. Sponsored ADR (GRCL) a Strong Momentum Stock: Buy Now?finance.yahoo.com - November 23 at 6:02 PMDoes Gracell Biotechnologies Inc. Sponsored ADR (GRCL) Have the Potential to Rally 120.94% as Wall Street Analysts Expect?finance.yahoo.com - November 23 at 1:02 PMGracell Biotechnologies Inc.: Gracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease Summitfinanznachrichten.de - November 16 at 1:00 PMGracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease Summitfinance.yahoo.com - November 16 at 1:00 PMPositive Outlook for Gracell Biotechnologies: Promising Translational Data and Financial Stability Backs Buy Ratingmarkets.businessinsider.com - November 14 at 11:57 PMGracell Biotechnologies: Promising Developments in Systemic Lupus Erythematosus Treatment Augment Buy Ratingmarkets.businessinsider.com - November 14 at 8:55 AM Get Gracell Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for GRCL and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. GRCL Media Mentions By Week GRCL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRCL News Sentiment▼0.000.32▲Average Medical News Sentiment GRCL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRCL Articles This Week▼02▲GRCL Articles Average Week Get Gracell Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for GRCL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OCUL News LAB News CRGX News ARCT News AUPH News PLRX News MD News LBPH News CTKB News KIDS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRCL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gracell Biotechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
